![Hepatitis A: Natural history, immunopathogenesis, and outcome - Phan - 2013 - Clinical Liver Disease - Wiley Online Library Hepatitis A: Natural history, immunopathogenesis, and outcome - Phan - 2013 - Clinical Liver Disease - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/eb138051-d3a4-4791-9406-5e8508f47677/cld253-fig-0002-m.jpg)
Hepatitis A: Natural history, immunopathogenesis, and outcome - Phan - 2013 - Clinical Liver Disease - Wiley Online Library
![Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease - Advances in Chronic Kidney Disease Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease - Advances in Chronic Kidney Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4102ace5-ea8c-4cb2-aa5a-fd2c4fe3f943/gr1_lrg.jpg)
Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease - Advances in Chronic Kidney Disease
![CDC LC Quick Learn: Using an Epi Curve to Determine Most Likely Period of Exposure - Exercise 2: Count Back the Average Incubation Period CDC LC Quick Learn: Using an Epi Curve to Determine Most Likely Period of Exposure - Exercise 2: Count Back the Average Incubation Period](https://www.cdc.gov/training/QuickLearns/exposure/images/exercise-2.png)
CDC LC Quick Learn: Using an Epi Curve to Determine Most Likely Period of Exposure - Exercise 2: Count Back the Average Incubation Period
Translation Directed by Hepatitis A Virus IRES in the Absence of Active eIF4F Complex and eIF2 | PLOS ONE
![Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection: Molecular Therapy - Methods & Clinical Development Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/1a91e195-81d4-44b6-b745-e71b9adfdc9c/fx1_lrg.jpg)
Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection: Molecular Therapy - Methods & Clinical Development
![Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells - Journal of Hepatology Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1b09258a-3ea4-4f29-ab55-4b8677d02cf3/ga1.jpg)
Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells - Journal of Hepatology
![Infectious Hepatitis — Detection of Virus during the Incubation Period and in Clinically Inapparent Infection | NEJM Infectious Hepatitis — Detection of Virus during the Incubation Period and in Clinically Inapparent Infection | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1959/nejm_1959.261.issue-15/nejm195910082611501/20130805/images/img_medium/nejm195910082611501_f5.jpeg)
Infectious Hepatitis — Detection of Virus during the Incubation Period and in Clinically Inapparent Infection | NEJM
![Pathogens | Free Full-Text | Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update | HTML Pathogens | Free Full-Text | Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update | HTML](https://www.mdpi.com/pathogens/pathogens-08-00063/article_deploy/html/images/pathogens-08-00063-g004.png)
Pathogens | Free Full-Text | Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update | HTML
![Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/11f54e1c-2994-433c-b95d-0bb9e6443896/fx1_lrg.jpg)